THE ROLE OF NEPHRON-SPARING SURGERY IN THE MANAGEMENT OF SMALL RENAL MASSES COMPARING THE ONCOLOGICAL OUTCOMES, RENAL FUNCTION PRESERVATION, AND COMPLICATION RATES OF PARTIAL NEPHRECTOMY VERSUS RADICAL NEPHRECTOMY

Main Article Content

Safdar Saeed
Syed Rafiuddin Shah
Najeebullah
Mohsin Naveed
Uzma Riaz
Mubashar Akram

Keywords

Small renal masses, partial nephrectomy, radical nephrectomy, nephron sparing surgery

Abstract

Background: Regarding oncological results and renal function, it is still unknown which patients with renal cell carcinoma (RCC) benefit more from partial nephrectomy (PN) as opposed to radical nephrectomy (RN).


Objective: To evaluate the role of nephron-sparing surgery in the management of small renal masses comparing the oncological outcomes, renal function preservation, and complication rates of partial nephrectomy versus radical nephrectomy.


Methods: This retrospective study was carried out at the Department of Urology Sindh Institute of Urology and Transplantation (SIUT) Karachi Pakistan. This study (n = 120) examines individuals who had RN or PN procedures between 2018 and 2023 in hindsight. Patients were matched by age, sex, RENAL score, and preoperative kidney function (eGFR) and categorized according to RN or PN. The eGFR change between the baseline and the 5-year follow-up was evaluated.


Results: 60 patients in each group for analysis following matching. The PN group showed a greater recurrence incidence than the RN group for patients categorized as low risk (p = 0.01). RN patients exhibited lower 1-year postoperative eGFR than PN patients (p < 0.001). When compared to PN, RN was more likely to cause new-onset chronic kidney disease (CKD) stage ≥3b (p < 0.001). Following PN, the complication rate was much greater (p = 0.003).


Conclusion: According to our research, PN has better postsurgical renal function. However, RN is a dependable course of treatment if maintaining renal function is not of utmost importance.

Abstract 117 | PDF Downloads 21

References

1. Ferlay J, Colombet M, Soerjomataram I, Dyba T, Randi G, Bettio M, et al. Cancer incidence and mortality patterns inEurope: Estimates for 40 countries and 25 major cancers in2018. Eur J Cancer. 2018;103:356-87.
2. Bukavina L, Bensalah K, Bray F, Carlo M, Challacombe B, Karam JA, et al. Epidemiology of Renal Cell Carcinoma: 2022 Update. Eur Urol. 2022;82(5):529-42.
3. Karakiewicz PI, Lewinshtein DJ, Chun FK, Briganti A, Guille F, Perrotte P, et al. Tumor size improves the accuracy of TNM predictions in patients with renal cancer. EurUrol. 2006;50(3):521-8; discussion 9.
4. Ljungberg B, Albiges L, Abu-Ghanem Y, Bedke J, Capitanio U, Dabestani S, et al. European Association of UrologyGuidelines on Renal Cell Carcinoma: The 2022 Update. EurUrol. 2022;82(4):399-410.
5. Mir MC, Derweesh I, Porpiglia F, Zargar H, Mottrie A, Autorino R. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A SystematicReview and Meta-analysis of Comparative Studies. EurUrol. 2017;71(4):606-17.
6. Van Poppel H, Da Pozzo L, Albrecht W, Matveev V, Bono A, Borkowski A, et al. A prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol. 2007;51(6):1606-15.
7. Fero K, Hamilton ZA, Bindayi A, Murphy JD, Derweesh IH. Utilization and quality outcomes of cT1a, cT1b and cT2a partial nephrectomy: analysis of the national cancer database. BJU Int. 2018;121(4):565-74.
8. Wood EL, Adibi M, Qiao W, Brandt J, Zhang M, Tamboli P, et al. Local Tumor Bed Recurrence Following Partial Nephrectomy in Patients with Small Renal Masses. J Urol. 2018;199(2):393-400.
9. Carvalho JAM, Nunes P, Tavares-da-Silva E, Parada B, Jarimba R, Moreira P, et al. Impact of Positive Surgical Margins After Partial Nephrectomy. Eur Urol Open Sci. 2020;21:41-6.
10. Abu-Ghanem Y, Ramon J, Berger R, Kaver I, Fridman E, Leibowitz-Amit R, Dotan ZA. Positive surgical margin following radical nephrectomy is an independent predictor of local recurrence and disease-specific survival. World Journal of Surgical Oncology. 2017;15(1): 193.
11. Scosyrev E, Messing EM, Sylvester R, Campbell S, Van Poppel H. Renal function after nephron-sparing surgery versus radical nephrectomy: results from EORTC randomized trial 30904. Eur Urol. 2014;65(2):372-7.
12. Van Poppel H, Da Pozzo L, Albrecht W, Matveev V, Bono A, Borkowski A, et al. A prospective, randomized EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol. 2011;59(4):543-52.
13. Jiang YL, Peng CX, Wang HZ, Qian LJ. Comparison of the long-term follow-up and perioperative outcomes of partial nephrectomy and radical nephrectomy for 4 cm to 7 cm enal cell carcinoma: a systematic review and meta-analysis. BMC Urol. 2019;19(1):48.
14. Zhang Y, Long G, Shang H, Ding B, Sun G, Ouyang W, et al. Comparison of the oncological, perioperative and functional outcomes of partial nephrectomy versus radical nephrectomy for clinical T1b renal cell carcinoma: A systematic review and meta-analysis of retrospective studies. Asian J Urol. 2021;8(1):117-25.
15. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604-12.
16. Kutikov A, Uzzo RG. The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol. 2009;182(3):844-53.
17. Ficarra V, Novara G, Secco S, Macchi V, Porzionato A, De Caro R, Artibani W. Preoperative aspects and dimensions used for an anatomical (PADUA) classification of renal tumours in patients who are candidates for nephron-sparing surgery. Eur Urol. 2009;56(5):786-93.
18. Leibovich BC, Blute ML, Cheville JC, Lohse CM, Frank I, Kwon ED, et al. Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. Cancer. 2003;97(7):1663-71.
19. Stevens PE, Levin A, Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group M. Evaluation and management of chronic kidney disease: Synopsis of the kidney disease: Improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158(11):825-30.
20. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205-13.
21. Jang HA, Kim JW, Byun SS, Hong SH, Kim YJ, Park YH, et al. Oncologic and Functional Outcomes after Partial Nephrectomy Versus Radical Nephrectomy in T1b Renal Cell Carcinoma: A Multicenter, Matched CaseControl Study in Korean Patients. Cancer Res Treat. 2016;48(2):612-20.
22. Weight CJ, Larson BT, Fergany AF, Gao T, Lane BR, Campbell SC, et al. Nephrectomy induced chronic renal insufficiency is associated with increased risk of cardiovascular death and death from any cause in patients with localized cT1b renal masses. J Urol. 2010;183(4):1317-23.
23. Capitanio U, Larcher A, Cianflone F, Trevisani F, Nini A, Mottrie A, et al. Hypertension and Cardiovascular Morbidity Following Surgery for Kidney Cancer. Eur Urol Oncol. 2020;3(2):209-15.
24. Capitanio U, Terrone C, Antonelli A, Minervini A, Volpe A, Furlan M, et al. Nephron-sparing techniques independently decrease the risk of cardiovascular events relative to radical nephrectomy in patients with a T1a-T1b renal mass and normal preoperative renal function. Eur Urol. 2015;67(4):683-9.
25. Lane BR, Demirjian S, Derweesh IH, Takagi T, Zhang Z, Velet L, et al. Survival and Functional Stability in Chronic Kidney Disease Due to Surgical Removal of Nephrons: Importance of the New Baseline Glomerular Filtration Rate. Eur Urol. 2015;68(6):996-1003.
26. Poulakis V, Witzsch U, de Vries R, Moeckel M, Becht E. Quality of life after surgery for localized renal cell carcinoma: Comparison between radical nephrectomy and nephron-sparing surgery. Urology. 2003;62(5):814-20.
27. UK CR. A study looking at two different types of surery for kidney cancer (PARTIAL) London, UK: Cancer Research UK; 2023 [updated 17-03-2023. Available from: https://www.cancerresearchuk.org/about-cancer/find-aclinical-trial/a-study-looking-at-two-different-types-ofsurgery-for-kidney-cancer-partial#undefined.
28. Ristau BT, Handorf EA, Cahn DB, Kutikov A, Uzzo RG, Smaldone MC. Partial nephrectomy is not associated with an overall survival advantage over radical nephrectomy in elderly patients with stage Ib-II renal masses: An analysis of the national cancer data base. Cancer. 2018;124(19):3839- 48.
29. Roos FC, Brenner W, Thomas C, Jager W, Thuroff JW, Hampel C, Jones J. Functional analysis of elective nephronsparing surgery vs. radical nephrectomy for renal tumors larger than 4 cm. Urology. 2012;79(3):607-13.
30. Deklaj T, Lifshitz DA, Shikanov SA, Katz MH, Zorn KC, Shalhav AL. Laparoscopic radical versus laparoscopic partial nephrectomy for clinical T1bN0M0 renal tumors: comparison of perioperative, pathological, and functional outcomes. J Endourol. 2010;24(10):1603-7.
31. Cerrato C, Patel D, Autorino R, Simone G, Yang B, Uzzo R, et al. Partial or radical nephrectomy for complex renal mass: a comparative analysis of oncological outcomes and complications from the ROSULA (Robotic Surgery for Large Renal Mass) Collaborative Group. World Journal of Urology. 2023;41(3):747-55.

Most read articles by the same author(s)